These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17761461)
21. [Vitamin D receptor gene Bsm I polymorphism and the susceptibility to prostate cancer in northern Chinese Han population]. Liu JH; Li HW; Wang JQ; Li M; Xin DQ; Na X; Zhang M; Ye SY; Na YQ Zhonghua Nan Ke Xue; 2003 Sep; 9(6):413-6. PubMed ID: 14574802 [TBL] [Abstract][Full Text] [Related]
22. Distribution of CFTR variations in an Indonesian enteric fever cohort. van de Vosse E; de Visser AW; Al-Attar S; Vossen R; Ali S; van Dissel JT Clin Infect Dis; 2010 May; 50(9):1231-7. PubMed ID: 20233062 [TBL] [Abstract][Full Text] [Related]
23. Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens. Radpour R; Gourabi H; Gilani MA; Dizaj AV J Androl; 2007; 28(4):541-7. PubMed ID: 17314234 [TBL] [Abstract][Full Text] [Related]
24. Two novel missense and one novel nonsense CFTR mutations in Iranian males with congenital bilateral absence of the vas deferens. Radpour R; Gourabi H; Gilani MA; Dizaj AV; Rezaee M; Mollamohamadi S Mol Hum Reprod; 2006 Nov; 12(11):717-21. PubMed ID: 16973827 [TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of defects in the CFTR gene and AZF locus of the Y chromosome in male infertility. Sobczyńska-Tomaszewska A; Bak D; Wolski JK; Bablok L; Nawara M; Mazurczak T; Bal J J Reprod Med; 2006 Feb; 51(2):120-7. PubMed ID: 16572913 [TBL] [Abstract][Full Text] [Related]
26. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis. Tzetis M; Kaliakatsos M; Fotoulaki M; Papatheodorou A; Doudounakis S; Tsezou A; Makrythanasis P; Kanavakis E; Nousia-Arvanitakis S Clin Genet; 2007 May; 71(5):451-7. PubMed ID: 17489851 [TBL] [Abstract][Full Text] [Related]
27. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression. Xu B; Wang J; Tong N; Mi Y; Min Z; Tao J; Li P; Cheng G; Li J; Wang M; Tang J; Song N; Zhang Z; Zhang W; Wu H; Hua L; Feng N Prostate; 2010 Jul; 70(10):1146-52. PubMed ID: 20333697 [TBL] [Abstract][Full Text] [Related]
28. Correlation between CFTR gene mutations in Iranian men with congenital absence of the vas deferens and anatomical genital phenotype. Radpour R; Gourabi H; Gilani MA; Dizaj AV J Androl; 2008; 29(1):35-40. PubMed ID: 17673436 [TBL] [Abstract][Full Text] [Related]
29. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population. Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786 [TBL] [Abstract][Full Text] [Related]
30. Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and T869C and the risk of gastric cancer in China. Li T; Cao BW; Dai Y; Cui H; Yang HL; Xu CQ J Gastroenterol Hepatol; 2008 Apr; 23(4):638-42. PubMed ID: 18341540 [TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Li M; Guan TY; Li Y; Na YQ Chin Med J (Engl); 2008 Feb; 121(4):305-8. PubMed ID: 18304461 [TBL] [Abstract][Full Text] [Related]
32. Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study. Ergen HA; Narter F; Timirci O; Isbir T Anticancer Res; 2007; 27(2):1227-30. PubMed ID: 17465268 [TBL] [Abstract][Full Text] [Related]
33. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Shaik AP; Jamil K; Das P Urol J; 2009; 6(2):78-86. PubMed ID: 19472123 [TBL] [Abstract][Full Text] [Related]
34. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731 [TBL] [Abstract][Full Text] [Related]
35. Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis. Urquhart DS; Allen J; Elrayess M; Fidler K; Klein N; Jaffé A Arch Immunol Ther Exp (Warsz); 2006; 54(4):271-6. PubMed ID: 16830219 [TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of CFTR gene mutations in Indian CF patients. Sharma N; Singh M; Kaur G; Thapa BR; Prasad R Ann Hum Genet; 2009 Jan; 73(1):26-33. PubMed ID: 18782298 [TBL] [Abstract][Full Text] [Related]
37. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan. Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269 [TBL] [Abstract][Full Text] [Related]
38. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345 [TBL] [Abstract][Full Text] [Related]
39. CFTR gene mutations and polymorphism are associated with non-obstructive azoospermia: From case-control study. Jiang L; Jin J; Wang S; Zhang F; Dai Y; Shi L; Zhang S Gene; 2017 Aug; 626():282-289. PubMed ID: 28456595 [TBL] [Abstract][Full Text] [Related]
40. The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania. Frenţescu L; Brownsell E; Hinks J; Malone G; Shaw H; Budişan L; Bulman M; Schwarz M; Pop L; Filip M; Tomescu E; Moşescu S; Popa I; Benga G J Cyst Fibros; 2008 Sep; 7(5):423-8. PubMed ID: 18467194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]